Translate
Maat Pharma
About
7.34EUR+0.05 +0.69%
Closed • Updated at 08:58 GMT+00:00Market Cap$161.08M
Volume32.2K
Beta0.05
RSI72.52
Gross Margin30.70%
Maat Pharma — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 1 2026
MaaT Pharma Announces Publication of Retrospective Data in Third-Line Acute GvHD from the CHRONOS Study in Bone Marrow Transplantation Journal
Mar 31 2026
MaaT Pharma Announces 2025 Annual Results and Provides Business Updates
Mar 23 2026
MaaT Pharma Presents the ARES Phase 3 Pivotal Trial Final Data During the Presidential Plenary Session at the 52nd Annual Meeting of the European Society for Bone and Marrow Transplantation
Mar 9 2026
MaaT Pharma to Present Four Abstracts at the 52nd European Bone Marrow Transplantation Annual Meeting and to Highlight Clinigen-Hosted Industry Symposium on acute GvHD Management
Feb 3 2026
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
Recent Videos
 yeah, Allah #Sabki Maat #pharma Ramzan Ke Mahine #Se In Ke saare Guna maaf kar 🤲
Mar 06, 2026
Le Journal des biotechs : Hervé Affagard, MaaT Pharma
Jan 26, 2026
Maat Pharma, un anticancer issu du microbiote : "On fournit d'ores et déjà le produit maison"
Nov 28, 2025
Eric Soyer, directeur financier MaaT Pharma: "Des moyens financiers renforcés"
Nov 26, 2025